1. Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy. Issue 1 (December 2017) Authors: Kang, Yong; Jang, Won; Kwon, Jong; Yoon, Cheol; Lee, Joo; Ham, Won; Choi, Young Journal: BMC cancer Issue: Volume 17:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗